ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTSettlement Agreement • February 8th, 2023
Contract Type FiledFebruary 8th, 2023Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTSettlement Agreement • February 8th, 2023
Contract Type FiledFebruary 8th, 2023Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTSettlement Agreement • December 20th, 2022
Contract Type FiledDecember 20th, 2022Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTSettlement Agreement • December 20th, 2022
Contract Type FiledDecember 20th, 2022Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTSettlement Agreement • December 20th, 2022
Contract Type FiledDecember 20th, 2022Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);